BRIEF published on 02/25/2026 at 22:20, 8 months 24 days ago NANOBIOTIX Presents at Key Conferences in March Biotechnology Investor Conferences Cancer Treatments NANOBIOTIX Clinical Advances
BRIEF published on 02/17/2026 at 22:20, 9 months 4 days ago Nanobiotix Announces Updated Voting Rights and Share Capital Euronext Paris Voting Rights Shares Capital Financial Disclosure NANOBIOTIX
PRESS RELEASE published on 02/17/2026 at 22:15, 9 months 4 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital. The biotech company is listed on Euronext Paris and Nasdaq, focusing on disruptive therapies Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/02/2026 at 09:44, 9 months 19 days ago Goldman Sachs reduces its stake in Nanobiotix Euronext Paris Goldman Sachs Threshold Crossing Transfer Of Shares NANOBIOTIX
BRIEF published on 01/26/2026 at 09:56, 9 months 26 days ago Goldman Sachs crosses thresholds in Nanobiotix Voting Rights Goldman Sachs Crossing Thresholds NANOBIOTIX Off-market Acquisition
BRIEF published on 01/13/2026 at 22:20, 10 months 8 days ago Nanobiotix Reports Voting Rights and Share Capital Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 01/13/2026 at 22:20, 10 months 8 days ago Nanobiotix's monthly information on shares and voting rights Voting Rights Euronext Actions Nasdaq NANOBIOTIX
PRESS RELEASE published on 01/13/2026 at 22:15, 10 months 8 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital. Listed on Euronext Paris and Nasdaq. Pioneering biotech company with disruptive therapeutic approaches Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 12/15/2025 at 08:35, 11 months 6 days ago NANOBIOTIX joins the CAC Mid 60 and SBF 120 indices Investors Biotechnology NANOBIOTIX CAC Mid 60 Stock Market Indices
BRIEF published on 12/15/2025 at 08:35, 11 months 6 days ago NANOBIOTIX to Enter CAC Mid 60 and SBF 120 Indices Euronext Paris Biotechnology SBF 120 NANOBIOTIX CAC Mid 60
Published on 11/20/2026 at 15:00, 1 day 15 hours ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 1 day 15 hours ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 1 day 16 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 1 day 17 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 1 day 17 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 1 day 6 hours ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 21:36, 1 day 9 hours ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 19:26, 1 day 11 hours ago EQS-Adhoc: TAKKT AG: TAKKT revises its 2026 full-year forecast following the cyberattack
Published on 11/20/2026 at 19:03, 1 day 11 hours ago EQS-Adhoc: Allgeier SE confirms rumors regarding sale process for the Evora Group
Published on 11/20/2026 at 18:34, 1 day 12 hours ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 1 day 13 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 2 days 11 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Published on 11/19/2026 at 08:30, 2 days 22 hours ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing